Cargando…
Metabolic syndrome and renal cell carcinoma
BACKGROUND: Metabolic syndrome (MS) is a cluster of metabolic abnormalities, which has been regarded as a pivotal risk factor for cardiovascular diseases. Recent studies focusing on the relationship between MS and cancer have recognized the significant role of MS on carcinogenesis. Likewise, growing...
Autores principales: | Zhang, Gui-Ming, Zhu, Yao, Ye, Ding-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118156/ https://www.ncbi.nlm.nih.gov/pubmed/25069390 http://dx.doi.org/10.1186/1477-7819-12-236 |
Ejemplares similares
-
Critical appraisal of sorafenib in the treatment of Chinese patients with renal cell carcinoma
por: Ye, Ding-Wei, et al.
Publicado: (2014) -
Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
por: Bobulescu, Ion Alexandru, et al.
Publicado: (2021) -
Modification of American Joint Committee on cancer prognostic groups for renal cell carcinoma
por: Shao, Ning, et al.
Publicado: (2018) -
Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies
por: Xiao, Yi, et al.
Publicado: (2019) -
Metabolic Syndrome and Renal Injury
por: Sheen, Yi-Jing, et al.
Publicado: (2011)